Revealed: A Real Solution for Depression?
Depression is the leading cause of disability worldwide. For nearly 100 million people… there's no known solution. That's right. Nearly one-third of the world's 322 million people suffering from depression have no existing treatment. But that's all about to change.
Here's how you could capitalize off this

OVID Insider Trading (Ovid Therapeutics)

Insider Ownership Percentage: 11.80%
Insider Buying (Last 12 Months): $49,569.92
Insider Selling (Last 12 Months): $0.00

Ovid Therapeutics Insider Trading History Chart

Ovid Therapeutics Share Price & Price History

$4.19
▼ -0.08 (-1.87%)
As of 06/22/2021 02:47 PM ET
Days: 30 | 90 | 365
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

Ovid Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/28/2020Jeremy M LevinCEOBuy8,488$5.84$49,569.925,792,530View SEC Filing Icon  
10/8/2019Jeremy M LevinCEOBuy60,000$2.13$127,800.00
10/8/2019Pharmaceutical Co Ltd TakedaMajor ShareholderBuy2,000,000$2.50$5,000,000.00View SEC Filing Icon  
2/26/2019Karen BernsteinDirectorBuy10,000$2.02$20,200.00View SEC Filing Icon  
2/22/2019Jeremy M LevinCEOBuy75,000$2.00$150,000.00View SEC Filing Icon  
8/14/2018Douglas E WilliamsDirectorBuy5,000$6.49$32,450.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ovid Therapeutics (NASDAQ:OVID)

53.49% of Ovid Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ovid Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/24/2021Principal Financial Group Inc.14,075$57K0.0%-42.8%0.021%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL6,417,551$25.80M1.0%+41.9%9.467%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.585,705$2.36M0.0%+175.8%0.864%Search for SEC Filing on Google Icon
5/18/2021Caxton Associates LP17,386$70K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley77,934$0.31M0.0%-48.1%0.115%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC48,891$0.20M0.0%N/A0.072%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC40,111$0.16M0.0%N/A0.059%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC64,000$0.26M0.0%N/A0.094%Search for SEC Filing on Google Icon
5/17/2021AQR Capital Management LLC122,059$0.49M0.0%+301.7%0.180%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada74,822$0.30M0.0%-9.1%0.110%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD36,748$0.15M0.0%N/A0.054%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC6,082,200$24.45M1.1%N/A8.972%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC170,026$0.68M0.0%-3.2%0.251%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC1,124,872$4.52M0.2%N/A1.659%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.751,565$3.02M0.0%+58.4%1.109%Search for SEC Filing on Google Icon
5/14/2021Quantbot Technologies LP13,400$53K0.0%N/A0.020%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC40,077$0.16M0.0%+160.9%0.059%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp151,030$0.61M0.0%+11.7%0.223%Search for SEC Filing on Google Icon
5/13/2021Blair William & Co. IL156,482$0.63M0.0%+13.7%0.231%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp481,863$1.94M0.0%-3.9%0.711%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC763,837$3.07M0.0%+33.6%1.127%Search for SEC Filing on Google Icon
5/12/2021Prudential Financial Inc.11,262$45K0.0%N/A0.017%Search for SEC Filing on Google Icon
5/12/2021DCF Advisers LLC109,001$0.44M0.2%N/A0.161%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.17,928$72K0.0%-14.9%0.026%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG20,037$81K0.0%-98.1%0.030%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC962,476$3.87M0.0%+172.9%1.420%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.104,283$0.42M0.0%N/A0.154%Search for SEC Filing on Google Icon
5/10/2021Principal Financial Group Inc.14,075$57K0.0%-42.8%0.021%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP75,888$0.31M0.1%-60.4%0.112%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.3,701,688$14.88M0.0%+8.5%5.461%Search for SEC Filing on Google Icon
5/6/2021Blueshift Asset Management LLC34,706$0.14M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/5/2021Newman Dignan & Sheerar Inc.18,522$74K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/5/2021Los Angeles Capital Management LLC32,860$0.13M0.0%-55.8%0.050%Search for SEC Filing on Google Icon
5/3/2021Great Lakes Advisors LLC16,893$68K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company31,332$0.13M0.0%N/A0.048%Search for SEC Filing on Google Icon
3/10/2021Los Angeles Capital Management LLC74,370$0.17M0.0%+4.5%0.117%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.24,619$57K0.0%N/A0.039%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.21,064$49K0.0%+32.0%0.033%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC70,987$0.16M0.0%-49.6%0.112%Search for SEC Filing on Google Icon
2/16/2021HighVista Strategies LLC40,920$95K0.1%N/A0.065%Search for SEC Filing on Google Icon
2/16/2021Baker BROS. Advisors LP955,690$2.21M0.0%+61.8%1.507%Search for SEC Filing on Google Icon
2/16/2021Tudor Investment Corp Et Al13,677$32K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC175,579$1.17M0.0%+2.9%0.277%Search for SEC Filing on Google Icon
2/16/2021Engineers Gate Manager LP13,000$30K0.0%-44.7%0.020%Search for SEC Filing on Google Icon
2/16/2021Gyon Technologies Capital Management LP88,008$0.20M0.1%+462.0%0.139%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.107,882$0.25M0.0%+10.7%0.170%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG14,568$33K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/12/2021CHI Advisors LLC827,260$1.91M0.5%+33.8%1.304%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp501,249$1.16M0.0%+3.5%0.790%Search for SEC Filing on Google Icon
2/11/2021Barclays PLC15,359$35K0.0%-40.1%0.024%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers49,670$0.12M0.0%+7.3%0.078%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC710,507$1.64M0.0%N/A1.120%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN551,759$1.27M0.0%+3.1%0.870%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp135,263$0.31M0.0%+11.3%0.213%Search for SEC Filing on Google Icon
2/9/2021Blair William & Co. IL137,660$0.32M0.0%-16.4%0.217%Search for SEC Filing on Google Icon
2/9/2021ProShare Advisors LLC20,333$47K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.3,411,733$7.88M0.0%+23.6%5.378%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP191,833$0.44M0.1%+237.3%0.302%Search for SEC Filing on Google Icon
2/2/2021First Trust Advisors LP98,223$0.23M0.0%+6.3%0.155%Search for SEC Filing on Google Icon
1/25/2021XTX Markets LLC33,836$78K0.2%+114.5%0.053%Search for SEC Filing on Google Icon
1/25/2021Strs Ohio23,600$54K0.0%+20.4%0.037%Search for SEC Filing on Google Icon
12/14/2020Strs Ohio19,600$0.11M0.0%+53.1%0.031%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC13,770$79K0.0%N/A0.022%Search for SEC Filing on Google Icon
11/17/2020Jane Street Group LLC35,087$0.20M0.0%+19.1%0.061%Search for SEC Filing on Google Icon
11/16/2020Point72 Hong Kong Ltd4,771$27K0.0%+1,372.5%0.008%Search for SEC Filing on Google Icon
11/16/2020JS Capital Management LLC18,700$0.11M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/16/2020AQR Capital Management LLC50,634$0.29M0.0%N/A0.089%Search for SEC Filing on Google Icon
11/16/2020OLD Mission Capital LLC55,200$0.32M0.0%N/A0.087%Search for SEC Filing on Google Icon
11/16/2020Squarepoint Ops LLC140,718$0.81M0.0%N/A0.247%Search for SEC Filing on Google Icon
11/16/2020ExodusPoint Capital Management LP14,561$84K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/16/2020Gyon Technologies Capital Management LP15,659$90K0.1%N/A0.027%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley129,526$0.74M0.0%-14.2%0.227%Search for SEC Filing on Google Icon
11/13/2020Vivo Capital LLC1,250,000$7.18M0.4%N/A2.190%Search for SEC Filing on Google Icon
11/13/2020Charles Schwab Investment Management Inc.97,439$0.56M0.0%-3.4%0.171%Search for SEC Filing on Google Icon
11/13/2020Virtus ETF Advisers LLC58,716$0.34M0.2%-12.0%0.103%Search for SEC Filing on Google Icon
11/13/2020Sofinnova Investments Inc.1,097,621$6.30M0.5%N/A1.923%Search for SEC Filing on Google Icon
11/13/2020AXA S.A.594,667$3.41M0.0%-16.2%1.042%Search for SEC Filing on Google Icon
11/13/2020Platinum Investment Management Ltd.233,413$1.34M0.0%-22.6%0.409%Search for SEC Filing on Google Icon
11/12/2020Connor Clark & Lunn Investment Management Ltd.149,989$0.86M0.0%-21.0%0.263%Search for SEC Filing on Google Icon
11/12/2020JPMorgan Chase & Co.15,960$95K0.0%-34.4%0.028%Search for SEC Filing on Google Icon
11/10/2020State Street Corp727,232$4.17M0.0%-1.2%1.274%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.2,759,691$15.84M0.0%-5.3%4.835%Search for SEC Filing on Google Icon
11/6/2020GSA Capital Partners LLP56,874$0.33M0.1%N/A0.100%Search for SEC Filing on Google Icon
11/6/2020Blair William & Co. IL164,736$0.95M0.0%+112.4%0.289%Search for SEC Filing on Google Icon
11/5/2020California Public Employees Retirement System97,424$0.56M0.0%+2.7%0.171%Search for SEC Filing on Google Icon
11/5/2020First Trust Advisors LP92,382$0.53M0.0%N/A0.162%Search for SEC Filing on Google Icon
11/5/2020Wells Fargo & Company MN535,086$3.07M0.0%+2.8%0.937%Search for SEC Filing on Google Icon
10/30/2020BNP Paribas Arbitrage SA9,762$56K0.0%+508.6%0.017%Search for SEC Filing on Google Icon
10/29/2020XTX Markets LLC15,771$91K0.4%N/A0.028%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.10,900$63K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/25/2020Nuveen Asset Management LLC203,275$1.50M0.0%N/A0.356%Search for SEC Filing on Google Icon
8/20/2020Charles Schwab Investment Management Inc.100,851$0.74M0.0%+442.9%0.177%Search for SEC Filing on Google Icon
8/17/2020Jane Street Group LLC29,455$0.22M0.0%-44.9%0.052%Search for SEC Filing on Google Icon
8/17/2020CHI Advisors LLC544,281$4.01M1.6%-34.3%0.953%Search for SEC Filing on Google Icon
8/14/2020Bank of America Corp DE20,887$0.15M0.0%-56.7%0.037%Search for SEC Filing on Google Icon
8/14/2020BVF Inc. IL2,392,151$17.63M1.1%+86.0%4.191%Search for SEC Filing on Google Icon
8/13/2020FMR LLC1,781,215$13.13M0.0%-14.6%3.121%Search for SEC Filing on Google Icon
8/12/2020Bank of Montreal Can3,417$27K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/12/2020American International Group Inc.26,183$0.19M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/12/2020CHI Advisors LLC544,281$4.01M2.1%-34.3%0.994%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ovid Therapeutics logo
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed Phase II clinical trial for the treatment of fragile X syndrome in adolescent and young male adults. It is also developing OV935, a drug candidate, which has completed Phase II clinical trial for the treatment of cyclin-dependent kinase-like 5 deficiency disorder and dravet syndrome. In addition, the company undertakes research programs exploring OV329 in infantile spasm/rare epilepsies; OV882 as a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815, a gene modulation therapy for the treatment of kinesin-family of proteins associated neurological disorder. Ovid Therapeutics Inc. has a collaboration agreement with Takeda Pharmaceutical Company Limited; a license agreement with H. Lundbeck A/S; strategic research collaboration with Columbia University Irving Medical Center; and license agreement with Angelini Pharma to develop and commercialize OV101 for the treatment of angelman syndrome in Europe. The company was incorporated in 2014 and is headquartered in New York, New York.
Read More on Ovid Therapeutics

Today's Range

Now: $4.19
$4.12
$4.26

50 Day Range

MA: $3.94
$3.30
$4.49

52 Week Range

Now: $4.19
$2.25
$4.80

Volume

4,604 shs

Average Volume

2,586,179 shs

Market Capitalization

$284.11 million

P/E Ratio

2.79

Dividend Yield

N/A

Beta

1.82

Who are the company insiders with the largest holdings of Ovid Therapeutics?

Ovid Therapeutics' top insider shareholders include:
  1. Jeremy M Levin (CEO)
  2. Pharmaceutical Co Ltd Takeda (Major Shareholder)

Who are the major institutional investors of Ovid Therapeutics?

Ovid Therapeutics' top institutional investors include:
  1. BVF Inc. IL — 9.47%
  2. EcoR1 Capital LLC — 8.97%
  3. BlackRock Inc. — 5.46%
  4. Ikarian Capital LLC — 1.66%
  5. Acadian Asset Management LLC — 1.42%
  6. Geode Capital Management LLC — 1.13%

Which institutional investors are selling Ovid Therapeutics stock?

During the last quarter, OVID stock was sold by these institutional investors:
  1. UBS Group AG
  2. GSA Capital Partners LLP
  3. Morgan Stanley
  4. Los Angeles Capital Management LLC
  5. Northern Trust Corp
  6. Principal Financial Group Inc.
  7. Principal Financial Group Inc.
  8. Royal Bank of Canada

Which institutional investors are buying Ovid Therapeutics stock?

Within the last quarter, OVID stock was purchased by institutional investors including:
  1. EcoR1 Capital LLC
  2. BVF Inc. IL
  3. Ikarian Capital LLC
  4. Acadian Asset Management LLC
  5. D. E. Shaw & Co. Inc.
  6. BlackRock Inc.
  7. Goldman Sachs Group Inc.
  8. Geode Capital Management LLC
In the last year, these company insiders have bought Ovid Therapeutics stock:
  1. Jeremy M Levin (CEO)
  2. Pharmaceutical Co Ltd Takeda (Major Shareholder)
One pot stock could skyrocket with looming interstate sales
A new bill in Congress would decriminalize marijuana nationally by removing cannabis from the federal government’s list of controlled substances. The law would also allow one established Seattle cannabis company to market across state lines for the first time – potentially setting off a bidding war that could blast this stock into the stratosphere!
Find Out Why This Could Be the #1 Pot Stock